Yıl: 2022 Cilt: 56 Sayı: 1 Sayfa Aralığı: 28 - 33 Metin Dili: İngilizce DOI: 10.4274/turkderm.galenos.2021.69797 İndeks Tarihi: 16-06-2022

Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study

Öz:
Background and Design: Although multiple investigations have been conducted to identify important serum biomarkers in patients with psoriasis, no simple, useful biomarker that could be specific for psoriasis has been identified. Objectives: 1) To determine the levels of serum uric acid (SUA), C-reactive protein (CRP), and neutrophil-to-lymphocyte ratio (NLR) among individuals with psoriasis and controls, 2) to assess the correlation of SUA and CRP levels and NLR with disease severity calculated through the psoriasis area severity index (PASI) in patients with psoriasis. Materials and Methods: A hospital-based, case-control study included 45 patients clinically diagnosed with psoriasis and 45 age- and sex- matched controls attending the outpatient dermatology clinic of our hospital. After a complete history was taken, and general, systemic, and cutaneous examinations were performed, all the cases were subjected to the following investigations: Complete blood count (NLR), CRP, and SUA. Results: Mean SUA level was significantly higher in the patients with psoriasis compared to the controls (p<0.01). However, no difference in CRP levels and NLR was observed (p>0.05). A significant correlation of SUA level and NLR was found with disease severity in the patients with psoriasis as determined by the PASI. In multivariate analysis, only SUA was found to be independently associated with psoriasis severity (p<0.05). Conclusion: The results showed that only SUA to be independently associated with psoriasis severity. No association was found between CRP levels and NLR and disease severity, as well as no difference between the disease and controls groups.
Anahtar Kelime:

Serum ürik asit, C-reaktif protein ve nötrofil/lenfosit oranının psoriazis ile ilişkisi: Bir olgu kontrol çalışması

Öz:
Amaç: Psoriazisli hastaların periferik kan örneklerinde yararlı biyobelirteçler bulmak amacıyla çok sayıda araştırma yapılmış olmasına rağmen, psoriazise özgü olabilecek basit ve klinik olarak yararlı bir biyobelirteç tanımlanmamıştır. Hedefler: 1) Psoriazisli hastalar ve kontroller arasında serum ürik asit (SÜA), C-reaktif protein (CRP) ve nötrofil/lenfosit oranını (NLO) belirlemek, 2) psoriazisi olan hastalarda SÜA seviyeleri, CRP, nötrofil/lenfosit oranı ve psoriazis alan şiddet indeksi (PAŞİ) ile hesaplanan hastalık şiddeti arasındaki ilişkiyi değerlendirmektir. Gereç ve Yöntem: Hastane bazlı bir olgu kontrol çalışmasına, hastanemizin dermatoloji polikliniğine başvuran, klinik olarak teşhis edilmiş 45 psoriazis olgusu, 45 yaş ve cinsiyet uyumlu kontrol dahil edilmiştir. Tam öykü, genel, sistemik ve kutanöz muayeneleri yapıldıktan sonra tüm olgularda tam kan sayımı (NLO), CRP ve SÜA incelemeleri yapılmBulgular: Psoriazis olguları arasında ortalama SÜA düzeyi kontrollere göre anlamlı derecede yüksekti (p<0,01). Ancak CRP düzeyleri ve NLO arasında fark gözlenmedi (p>0,05). Psoriazisli hastalarda SÜA ve NLO ile, PAŞİ skoru ile belirlenen hastalık şiddeti arasında anlamlı bir korelasyon gözlendi. Çok değişkenli analizde, sadece SÜA’nın, psoriazis şiddeti ile bağımsız olarak bir ilişki gösterdiği belirlendi (p<0,05). Sonuç: Bu çalışmanın sonuçları, yalnızca SÜA’nın bağımsız olarak psoriazis şiddeti ile ilişkili olduğunu gösterdi. CRP seviyeleri ile NLO ve hastalık şiddeti arasında hiçbir ilişki gözlenmedi, hastalık ve kontrol grupları arasında da herhangi bir fark kaydedilme
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • . Weinberg JM, Lebwohl M: Advances in psoriasis. A Multisystemic Guide, Springer; 2014.
  • 2. Naldi L, Gambini D: The clinical spectrum of psoriasis. Clin Dermatol 2007;25:510-8.
  • 3. Villanova F, Di Meglio P, Nestle FO: Biomarkers in psoriasis and psoriatic arthritis. Ann Rheum Dis 2013;72:104-10.
  • 4. Pepys MB, Hirschfield GM: C-reactive protein: A critical update. J Clin Invest 2003;111:1805-12.
  • 5. Paller D, Petrou I: Pediatric psoriasis: C-reactive protein levels associated with disease severity. J Invest Dermatol 2009;102:219-27.
  • 6. Strober B, Teller C, Yamauchi P, et al.: C-reactive protein levels in psoriasis and psoriatic arthritis. Br J Dermatol 2008;159:322-30.
  • 7. Balta S, Celik T, Mikhailidis DP, et al.: The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost 2016;22:405-11.
  • 8. Özer S, Yılmaz R, Sönmezgöz E, et al.: Simple markers for subclinical inflammation in patients with familial mediterranean fever. Med Sci Monit 2015;21:298-303.
  • 9. Qin B, Ma N, Tang Q, et al.: Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 2016;26:372-6.
  • 10. Janik S, Raunegger T, Hacker P, et al.: Prognostic and diagnostic impact of fibrinogen, neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio on thymic epithelial tumors outcome. Oncotarget 2018;9:21861- 75.
  • 11. Sen BB, Rifaioglu EN, Ekiz O, Inan MU, Sen T, Sen N: Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol 2014;33:223-7.
  • 12. Lubrano E, Cantini F, Costanzo A, et al.: Measuring psoriatic disease in clinical practice. An expert opinion position paper. Autoimmun Rev 2015;14:864-74. 13. Grozdev I, Korman N, Tsankov N: Psoriasis as a systemic disease. Clin Dermatol 2014;32:343-50.
  • 14. Kanbay M, Solak Y, Dogan E, Lanaspa MA, Covic A: Uric acid in hypertension and renal disease: the chicken or the egg? Blood Purif 2010;30:288-95.
  • 15. Billiet L, Doaty S, Katz JD, Velasquez MT: Review of hyperuricemia as new marker for metabolic syndrome. ISRN Rheumatol 2014;2014:852954.
  • 16. Ishizaka Y, Yamakado M, Toda A, Tani M, Ishizaka N: Relationship between serum uric acid and serum oxidative stress markers in the Japanese general population. Nephron Clin Pract 2014;128:49-56.
  • 17. Kanbay M, Yilmaz MI, Apetrii M, et al.: Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients. Am J Nephrol 2012;36:228-37.
  • 18. Kanbay M, Huddam B, Azak A, et al.: A randomized study of allopurinol on endothelial function and estimated glomerular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol 2011;6:1887-94.
  • 19. Gisondi P, Targher G, Cagalli A, Girolomoni G: Hyperuricemia in patients with chronic plaque psoriasis. J Am Acad Dermatol 2014;70:127-30
  • 20. Li X, Miao X, Wang H, et al.: Association of serum uric acid levels in psoriasis: A systematic review and meta-analysis. Medicine (Baltimore) 2016;95:e3676.
  • 21. Solak B, Dikicier BS, Erdem T: Impact of elevated serum uric acid levels on systemic inflammation in patients with psoriasis. Angiology 2017;68:266-70.
  • 22. Ciray H, Aksoy AH, Ulu N, Cizmecioglu A, Gaipov A, Solak Y: Nephropathy, but not angiographically proven retinopathy, is associated with neutrophil to lymphocyte ratio in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 2015;123:267-71.
  • 23. Biyik M, Ucar R, Solak Y, et al.: Blood neutrophil-to-lymphocyte ratio independently predicts survival in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2013;25:435-41.
  • 24. Ataseven A, Bilgin AU, Kurtipek GS: The importance of neutrophil lymphocyte ratio in patients with psoriasis. Mater Sociomed 2014;26:231-3.
  • 25. Kim DS, Shin D, Lee MS, et al.: Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol 2016;43:305-10.
  • 26. Ataseven A, Bilgin AU, Kurtipek GS: The importance of neutrophil lymphocyte ratio in patients with psoriasis. Mater Sociomed 2014;26:231-3.
  • 27. Sunbul M, Seckin D, Durmus E, et al.: Assessment of arterial stiffness and cardiovascular hemodynamics by oscillometric method in psoriasis patients with normal cardiac functions. Heart Vessels 2015;30:347-54.
  • 28. Yadav SK, Sharma S, Singh S, Khurana VK, Sarin N: Neutrophil to lymphocyte ratio and platelet lymphocyte ratio: Novel markers of inflammation in psoriasis. Annals of Pathology and Laboratory Medicine 2019;6:387-91.
  • 29. Paliogiannis P, Satta R, Deligia G: Association between neutrophil lymphocyte ratio and platelet lymphocyte ratio and presence of psoriasis: A systematic review and meta-analysis. Clin Exp Med 2019;19:37-45.
  • 30. Blake GJ, Ridker PM: Novel clinical markers of vascular wall inflammation. Circ Res 2001;89:763-71.
  • 31. Choudhury RP, Leyva F: C-Reactive protein, serum amyloid A protein and coronary events. Circulation 1999;100:65-6.
  • 32. Steel DM, Whitehead AS: The major acute phase reactants: C reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81-8.
  • 33. Balta S, Balta I, Mikhailidis DP, et al.: Bilirubin levels and their association with carotid intima media thickness and high-sensitivity C-reactive protein in patients with psoriasis vulgaris. Am J Clin Dermatol 2014;15:137-42.
  • 34. Balta I, Balta S, Demirkol S, et al.: Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol 2013;169:1066-70.
  • 35. Gupta S, Garg P, Gupta N, Gupta N: High sensitivity C-reactive protein, a predictor of cardiovascular mortality and morbidity and psoriasis: A case control study. Int J Res Dermatol 2019;5:338-41.
  • 36. Vadakayil AR, Dandekeri S, Kambil SM, Ali NM: Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis. Indian Dermatol Online J 2015;6:3
APA MİSHRA S, KADNUR M, JARTARKAR S, KELOJİ H, AGARWAL R, BABU S (2022). Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. , 28 - 33. 10.4274/turkderm.galenos.2021.69797
Chicago MİSHRA Swayamsidda,KADNUR Manjunath,JARTARKAR Shishira R.,KELOJİ Hanumanthayya,AGARWAL Ritu,BABU Spoorthy Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. (2022): 28 - 33. 10.4274/turkderm.galenos.2021.69797
MLA MİSHRA Swayamsidda,KADNUR Manjunath,JARTARKAR Shishira R.,KELOJİ Hanumanthayya,AGARWAL Ritu,BABU Spoorthy Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. , 2022, ss.28 - 33. 10.4274/turkderm.galenos.2021.69797
AMA MİSHRA S,KADNUR M,JARTARKAR S,KELOJİ H,AGARWAL R,BABU S Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. . 2022; 28 - 33. 10.4274/turkderm.galenos.2021.69797
Vancouver MİSHRA S,KADNUR M,JARTARKAR S,KELOJİ H,AGARWAL R,BABU S Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. . 2022; 28 - 33. 10.4274/turkderm.galenos.2021.69797
IEEE MİSHRA S,KADNUR M,JARTARKAR S,KELOJİ H,AGARWAL R,BABU S "Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study." , ss.28 - 33, 2022. 10.4274/turkderm.galenos.2021.69797
ISNAD MİSHRA, Swayamsidda vd. "Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study". (2022), 28-33. https://doi.org/10.4274/turkderm.galenos.2021.69797
APA MİSHRA S, KADNUR M, JARTARKAR S, KELOJİ H, AGARWAL R, BABU S (2022). Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. Türkderm Türk deri hastalıkları ve frengi arşivi, 56(1), 28 - 33. 10.4274/turkderm.galenos.2021.69797
Chicago MİSHRA Swayamsidda,KADNUR Manjunath,JARTARKAR Shishira R.,KELOJİ Hanumanthayya,AGARWAL Ritu,BABU Spoorthy Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. Türkderm Türk deri hastalıkları ve frengi arşivi 56, no.1 (2022): 28 - 33. 10.4274/turkderm.galenos.2021.69797
MLA MİSHRA Swayamsidda,KADNUR Manjunath,JARTARKAR Shishira R.,KELOJİ Hanumanthayya,AGARWAL Ritu,BABU Spoorthy Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. Türkderm Türk deri hastalıkları ve frengi arşivi, vol.56, no.1, 2022, ss.28 - 33. 10.4274/turkderm.galenos.2021.69797
AMA MİSHRA S,KADNUR M,JARTARKAR S,KELOJİ H,AGARWAL R,BABU S Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. Türkderm Türk deri hastalıkları ve frengi arşivi. 2022; 56(1): 28 - 33. 10.4274/turkderm.galenos.2021.69797
Vancouver MİSHRA S,KADNUR M,JARTARKAR S,KELOJİ H,AGARWAL R,BABU S Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study. Türkderm Türk deri hastalıkları ve frengi arşivi. 2022; 56(1): 28 - 33. 10.4274/turkderm.galenos.2021.69797
IEEE MİSHRA S,KADNUR M,JARTARKAR S,KELOJİ H,AGARWAL R,BABU S "Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study." Türkderm Türk deri hastalıkları ve frengi arşivi, 56, ss.28 - 33, 2022. 10.4274/turkderm.galenos.2021.69797
ISNAD MİSHRA, Swayamsidda vd. "Correlation between serum uric acid, C-reactive protein, and neutrophil-to-lymphocyte ratio in patients with psoriasis: A case-control study". Türkderm Türk deri hastalıkları ve frengi arşivi 56/1 (2022), 28-33. https://doi.org/10.4274/turkderm.galenos.2021.69797